In NASH patients, NOX2 is significantly upregulated and dark chocolate intake has been shown in this study to reduce serum levels of sNOX2-dp, isoprostanes, and CK-18. The gene discussed is KRT18; the disease is metabolic dysfunction-associated steatohepatitis.